ASEP MEDICAL HOLDINGS INC - SEPSF STOCK NEWS

Welcome to our dedicated page for ASEP MEDICAL HOLDINGS news (Ticker: SEPSF), a resource for investors and traders seeking the latest updates and insights on ASEP MEDICAL HOLDINGS stock.

Asep Medical Holdings Inc. (SEPSF) is a leading company dedicated to addressing the global issue of antibiotic failure through innovative solutions for unmet medical needs. The company comprises three private companies with advanced technologies, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc. Sepset Biosciences focuses on early sepsis identification, ABT Innovations on biofilm infections, and SafeCoat Medical on antimicrobial coatings for medical devices. The company's groundbreaking AI-based technologies and diagnostic tools aim to revolutionize the medical industry.

07/14/2023 07:00 PM

News

Another Breakthrough-- Asep Inc.';s A.I.-Based Sepsis Technology Identifies COVID-19 Severity from a Blood Sample

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

07/03/2023 06:00 PM

News

Asep Inc. Completes Submission of Registration Statement for NASDAQ Listing

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

06/23/2023 07:00 PM

News

Asep Inc. Receives Grant from NanoMedicines Innovation Network (NMIN), Funded by the Government of Canada

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

06/20/2023 07:00 AM

News

Asep Inc. Founder, Chair and CEO, Dr. Robert E. W. Hancock, Ranked 4th Best Microbiologist in the World

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

06/16/2023 07:00 PM

News

Asep Inc. Undertakes Final Steps Toward NASDAQ Listing

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

06/09/2023 07:00 PM

News

Asep Inc. Signs Definitive Agreement for Joint Venture with Bahrain-based Seaspring W.L.L. for Regulatory Approval and Commercialization of Sepsis Diagnosis Technology in the Kingdom of Bahrain, the Middle East and North Africa

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

06/02/2023 07:00 PM

News

Asep Inc. Announces Ground-breaking A.I. Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

05/30/2023 08:00 PM

News

Asep Inc. Engages Aegis Capital Corporation for Listing on NASDAQ Stock Exchange

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

01/27/2023 07:00 PM

News

Asep Inc. Signs Joint Venture Term Sheet with Leading Chinese Medical Diagnostic Company Sansure Biotech Inc. in Preparation for the Commercialization of the Sepset(ER) Sepsis Diagnostic Test in China

Rhea-AI Summary

Asep Medical Holdings Inc. (OTCQB: SEPSF) announced a joint venture with Sansure Biotech Inc. on January 27, 2023, aimed at commercializing the Sepset^ER sepsis diagnostic kit in China. The agreement, signed on September 29, 2022, outlines collaboration terms for research, development, and sublicensing in the Chinese market. Sansure will invest capital and Asep will receive royalties on sales. With a high sepsis mortality rate in China, this partnership is positioned to offer advanced diagnostic solutions, enhancing early detection capabilities while potentially reducing antibiotic resistance.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

01/18/2023 07:00 AM

News

Asep Medical Holdings Inc. to Hold Important Investor Information Webinar on January 24, 2023

Rhea-AI Summary

Asep Medical Holdings Inc. (CSE: ASEP, OTCQB: SEPSF) announced an online webinar on January 24, 2023, at 1:00 pm EST, to discuss global market developments, scientific advances, and investment milestones. Key topics include updates on the acquisition of SafeCoat Medical Inc., a joint venture with Bahrain's Seaspring W.L.L., and advancements in their sepsis diagnostic test kit, Sepset^ME. The webinar will also cover a feasibility study for an antibacterial mouthwash in China and the development of new wound bandages. The company aims to address significant medical needs associated with antibiotic failure.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

FAQ

What is the current stock price of ASEP MEDICAL HOLDINGS (SEPSF)?

The current stock price of ASEP MEDICAL HOLDINGS (SEPSF) is $0.065 as of October 15, 2024.

What is the market cap of ASEP MEDICAL HOLDINGS (SEPSF)?

The market cap of ASEP MEDICAL HOLDINGS (SEPSF) is approximately 3.8M.

What is Asep Medical Holdings Inc. focused on?

Asep Medical Holdings Inc. is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine.

Which companies are part of Asep Medical Holdings Inc.?

The company comprises three existing private companies with technology in advanced development, including Sepset Biosciences Inc., ABT Innovations Inc., and SafeCoat Medical Inc.

What is Sepset Biosciences Inc. working on?

Sepset Biosciences Inc. is developing proprietary diagnostic tools that enable the early and timely identification of sepsis, a significant disease leading to antibiotic failure.

What is the focus of ABT Innovations Inc.?

ABT Innovations Inc. covers a broad range of therapeutic applications, including bacterial biofilm infections, anti-inflammatories, immune-modulators, and vaccine adjuvants, addressing multi-drug resistant biofilm infections.

What is SafeCoat Medical Inc. known for?

SafeCoat Medical Inc. specializes in antimicrobial peptide medical device coating technology, offering anti-fouling coatings for various medical devices and implants.

What are the key achievements of Asep Medical Holdings Inc.?

Asep Medical Holdings Inc. has developed groundbreaking AI-based technologies and diagnostic tools, aiming to revolutionize the medical industry by addressing critical health issues such as antibiotic failure and biofilm infections.

What is the significance of Asep Medical Holdings Inc.'s joint venture with Sansure Biotech Inc.?

The joint venture with Sansure Biotech Inc. marks a significant milestone for Asep Medical Holdings Inc., allowing the company to expand its reach and commercialize its innovative diagnostics and therapeutic solutions.

How can investors stay informed about Asep Medical Holdings Inc.'s latest developments?

Investors, potential investors, analysts, and members of the medical community can register for the company's webinars to receive significant updates on the latest milestones, corporate presentations, global partnerships, and joint ventures.

What sets Asep Medical Holdings Inc. apart in the medical industry?

Asep Medical Holdings Inc. stands out in the medical industry for its cutting-edge AI-based technologies, innovative diagnostic tools, and focus on addressing critical health issues such as antibiotic failure, biofilm infections, and antimicrobial coatings.

How does Asep Medical Holdings Inc. contribute to the healthcare sector?

Asep Medical Holdings Inc. contributes to the healthcare sector by developing novel solutions for significant unmet medical needs, pioneering advanced technologies in diagnostics and therapeutics to improve patient outcomes and address global health challenges.